In A-fib patients selected using established dose-reduction criteria, the 2.5-mg twice daily dose of apixaban (Eliquis; Bristol-Myers Squibb) provides protection against stroke and death versus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback